Back
Revance Therapeutics Vs. MEI Pharma Industry Stock Comparison
Sell
9
RVNC
Revance Therapeutics
Last Price:
3.73
Seasonality Move:
6.97%
Sell
41
MEIP
MEI Pharma
Last Price:
2.79
Seasonality Move:
-0.42%
Sell
9
Revance Therapeutics (RVNC)
is a Sell
Is Revance Therapeutics a Buy, Sell or Hold?
- The current Revance Therapeutics [RVNC] share price is $3.73. The Score for RVNC is 9, which is 82% below its historic median score of 50, and infers higher risk than normal.
- RVNC is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
41
MEI Pharma (MEIP)
is a Sell
Is MEI Pharma a Buy, Sell or Hold?
- The current MEI Pharma [MEIP] share price is $2.78. The Score for MEIP is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
- MEIP is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
RVNC Stock Price Chart
What is Revance Therapeutics's stock price today?
-
The Revance Therapeutics share price today is $3.73
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RVNC is experiencing selling pressure, which indicates risk of future bearish movement.
MEIP Stock Price Chart
What is MEI Pharma's stock price today?
-
The MEI Pharma share price today is $2.78
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MEIP is experiencing selling pressure, which indicates risk of future bearish movement.
RVNC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.45 | Sell |
Relative Strength Index (14 RSI): | 32.99 | Sell |
Chaikin Money Flow: | -1111191 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (3.97 - 5.77) | Sell |
Bollinger Bands (100): | (3.78 - 6.28) | Sell |
MEIP Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.02 | Sell |
Relative Strength Index (14 RSI): | 36.78 | Sell |
Chaikin Money Flow: | -8290 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.8 - 3.1) | Sell |
Bollinger Bands (100): | (2.79 - 3.29) | Sell |
RVNC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 3.98 | Sell |
20-day SMA: | 4.79 | Sell |
50-day SMA: | 5.16 | Sell |
200-day SMA: | 4.6 | Sell |
8-day EMA: | 3.99 | Sell |
20-day EMA: | 4.48 | Sell |
50-day EMA: | 4.92 | Sell |
200-day EMA: | 6.01 | Sell |
MEIP Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.89 | Sell |
20-day SMA: | 3 | Sell |
50-day SMA: | 2.9 | Sell |
200-day SMA: | 3.26 | Sell |
8-day EMA: | 2.87 | Sell |
20-day EMA: | 2.92 | Sell |
50-day EMA: | 2.95 | Sell |
200-day EMA: | 3.57 | Sell |
Revance Therapeutics Earnings Growth & RVNC Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.31 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.51 per share, and an increase next year of $0.58 per share.
MEI Pharma Earnings Growth & MEIP Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $10.14 per share, and a decrease next year of $8.92 per share.
Revance Therapeutics Technical Analysis
Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
MEI Pharma Technical Analysis
Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |